Peter N. Laivins
2015
In 2015, Peter N. Laivins earned a total compensation of $1.3M as Former Head of Development at Merrimack Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $110,185 |
|---|---|
| Option Awards | $826,065 |
| Salary | $304,645 |
| Other | $15,473 |
| Total | $1,256,368 |
Laivins received $826.1K in option awards, accounting for 66% of the total pay in 2015.
Laivins also received $110.2K in non-equity incentive plan, $304.6K in salary and $15.5K in other compensation.
Rankings
In 2015, Peter N. Laivins' compensation ranked 6,827th out of 13,638 executives tracked by ExecPay. In other words, Laivins earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,827 out of 13,638 | 50th |
Division Manufacturing | 2,572 out of 5,190 | 50th |
Major group Chemicals And Allied Products | 926 out of 1,854 | 50th |
Industry group Drugs | 745 out of 1,528 | 51st |
Industry Pharmaceutical Preparations | 580 out of 1,182 | 51st |
Source: SEC filing on June 26, 2017.
Laivins' colleagues
We found four more compensation records of executives who worked with Peter N. Laivins at Merrimack Pharmaceuticals in 2015.
2015
Yasir Al-Wakeel
Merrimack Pharmaceuticals
Chief Financial Officer
2015
Robert Mulroy
Merrimack Pharmaceuticals
Chief Executive Officer
2015
William McClements
Merrimack Pharmaceuticals
Former Head of Corporate Operations
2015
Edward Stewart
Merrimack Pharmaceuticals